K-301

N/A

Report date: 2023/02/18 19:47:20
NME

Base Information

Drug NameK-301
Drug Alias NameK-40K-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEczema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMoberg Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMoberg Pharma Ab
Active IndicationsN/A
Inactive IndicationsEczema

Other Information

ATC CodeN/A
Related LinksN/A